Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy fornon-small-cell lung cancer
Titel:
Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy fornon-small-cell lung cancer
Auteur:
Quoix, E. Lebeau, B. Depierre, A. Ducolone, A. Moro-Sibilot, D. Milleron, B. Breton, J.L. Lemarie, E. Pujol, J.L. Brechot, J.M. Zalcman, G. Debieuvre, D. Vaylet, F. Vergnenegre, A. Clouet, P.